Mycobacteria Registry Study: Prospective Observational Study in Austria

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2053-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:

What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?

Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis

NCT05621343

Latent Tuberculosis Persistent Infection Mycobacterium Tuberculosis

RECRUITING

A Registry for Nontuberculous Mycobacterial Pulmonary Disease

NCT04078412

Nontuberculous Mycobacterial Pulmonary Disease

ENROLLING_BY_INVITATION

A Registry of Tuberculosis Cases in the CPCRA

NCT00000785

HIV Infections Tuberculosis

COMPLETED

Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis

NCT06764576

Mycobacterial Infection Tuberculosis (TB)

RECRUITING

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

NCT00000796

HIV Infections Tuberculosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Tuberculous Mycobacterial Pneumonia Tuberculosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
* individuals aged 18 years or older
* written informed consent